Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD5423 in mild allergic asthma
NCT01225549Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2010
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of AZD5423 in allergic asthma, sponsored by AstraZeneca. Started Nov 2010; status: completed.
02
Drugs
AZD5423
03
Conditions
allergic asthma
Beyond the preview
Go deeper on NCT01225549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01225549.